Alembic Pharmaceuticals appoints new chief financial officer

Alembic Pharmaceuticals announced the appointment of G. Krishnan as its new Chief Financial Officer (CFO) and Key Managerial Personnel, effective July 7, 2025. Krishnan, a qualified CA, CS, and CMA, brings over 22 years of experience spanning pharmaceuticals, life sciences, telecom, and social sectors. Prior to joining Alembic, he served as Vice President and CFO of Syngene Scientific Solutions Limited. His background includes expertise in business finance, mergers and acquisitions, and the implementation of scalable systems. The company has duly informed both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) regarding this key management change, complying with SEBI regulations.